abstract |
The invention relates to the compounds of formula (I), wherein R1a-R1e, R2a, R2b, R3 and X are defined as in claim 1. The inventive derivatives are tyrosinkinase inhibitors, especially inhibitors of TIE-2, and Raf kinase inhibitors and may inter alia be used for treating tumors. |